Global Liraglutide Market Insights and Forecast to 2028

Q: How big is the liraglutide market?

In 2015 Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weightrelated comorbid condition.Market Analysis and Insights Global Liraglutide MarketDue to the COVID19 pandemic the global Liraglutide market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

Q: Who are the key players in the liraglutide market?

Some of the key players are Novo Nordisk, Novo Nordisk, HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm, Russia, Others.

Code: QYRE-Auto-17139

Report

January 2022

Pages:88

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

HEC Pharm

Bachem

Bharat Pharmaceuticals

Kingpep Biotechnology

Shenzhen JYMed Technology

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Market Analysis and Insights: Global Liraglutide Market

Due to the COVID-19 pandemic, the global Liraglutide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Pills accounting for % of the Liraglutide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

China Liraglutide market size is valued at US$ million in 2021, while the US and Europe Liraglutide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Liraglutide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide and AmbioPharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Liraglutide Scope and Segment

Liraglutide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Liraglutide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Pills

Liquid

Segment by Application

Hospital

Drug Store

BY COMPANY

HEC Pharm

Bachem

Bharat Pharmaceuticals

Kingpep Biotechnology

Shenzhen JYMed Technology

Wuxi Asiapeptide

AmbioPharm

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

FEATURED COMPANIES

HEC Pharm

Bachem

Bharat Pharmaceuticals

Kingpep Biotechnology

Shenzhen JYMed Technology

1 Study Coverage

1.1 Liraglutide Product Introduction

1.2 Market by Type

1.2.1 Global Liraglutide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Pills

1.2.3 Liquid

1.3 Market by Application

1.3.1 Global Liraglutide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Drug Store

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Liraglutide Sales Estimates and Forecasts 2017-2028

2.2 Global Liraglutide Revenue Estimates and Forecasts 2017-2028

2.3 Global Liraglutide Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Liraglutide Sales by Region

2.4.1 Global Liraglutide Sales by Region (2017-2022)

2.4.2 Global Sales Liraglutide by Region (2023-2028)

2.5 Global Liraglutide Revenue by Region

2.5.1 Global Liraglutide Revenue by Region (2017-2022)

2.5.2 Global Liraglutide Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Liraglutide Sales by Manufacturers

3.1.1 Global Top Liraglutide Manufacturers by Sales (2017-2022)

3.1.2 Global Liraglutide Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liraglutide in 2021

3.2 Global Liraglutide Revenue by Manufacturers

3.2.1 Global Liraglutide Revenue by Manufacturers (2017-2022)

3.2.2 Global Liraglutide Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Liraglutide Revenue in 2021

3.3 Global Liraglutide Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Liraglutide Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Liraglutide Sales by Type

4.1.1 Global Liraglutide Historical Sales by Type (2017-2022)

4.1.2 Global Liraglutide Forecasted Sales by Type (2023-2028)

4.1.3 Global Liraglutide Sales Market Share by Type (2017-2028)

4.2 Global Liraglutide Revenue by Type

4.2.1 Global Liraglutide Historical Revenue by Type (2017-2022)

4.2.2 Global Liraglutide Forecasted Revenue by Type (2023-2028)

4.2.3 Global Liraglutide Revenue Market Share by Type (2017-2028)

4.3 Global Liraglutide Price by Type

4.3.1 Global Liraglutide Price by Type (2017-2022)

4.3.2 Global Liraglutide Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Liraglutide Sales by Application

5.1.1 Global Liraglutide Historical Sales by Application (2017-2022)

5.1.2 Global Liraglutide Forecasted Sales by Application (2023-2028)

5.1.3 Global Liraglutide Sales Market Share by Application (2017-2028)

5.2 Global Liraglutide Revenue by Application

5.2.1 Global Liraglutide Historical Revenue by Application (2017-2022)

5.2.2 Global Liraglutide Forecasted Revenue by Application (2023-2028)

5.2.3 Global Liraglutide Revenue Market Share by Application (2017-2028)

5.3 Global Liraglutide Price by Application

5.3.1 Global Liraglutide Price by Application (2017-2022)

5.3.2 Global Liraglutide Price Forecast by Application (2023-2028)

6 North America

6.1 North America Liraglutide Market Size by Type

6.1.1 North America Liraglutide Sales by Type (2017-2028)

6.1.2 North America Liraglutide Revenue by Type (2017-2028)

6.2 North America Liraglutide Market Size by Application

6.2.1 North America Liraglutide Sales by Application (2017-2028)

6.2.2 North America Liraglutide Revenue by Application (2017-2028)

6.3 North America Liraglutide Market Size by Country

6.3.1 North America Liraglutide Sales by Country (2017-2028)

6.3.2 North America Liraglutide Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Liraglutide Market Size by Type

7.1.1 Europe Liraglutide Sales by Type (2017-2028)

7.1.2 Europe Liraglutide Revenue by Type (2017-2028)

7.2 Europe Liraglutide Market Size by Application

7.2.1 Europe Liraglutide Sales by Application (2017-2028)

7.2.2 Europe Liraglutide Revenue by Application (2017-2028)

7.3 Europe Liraglutide Market Size by Country

7.3.1 Europe Liraglutide Sales by Country (2017-2028)

7.3.2 Europe Liraglutide Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Liraglutide Market Size by Type

8.1.1 Asia Pacific Liraglutide Sales by Type (2017-2028)

8.1.2 Asia Pacific Liraglutide Revenue by Type (2017-2028)

8.2 Asia Pacific Liraglutide Market Size by Application

8.2.1 Asia Pacific Liraglutide Sales by Application (2017-2028)

8.2.2 Asia Pacific Liraglutide Revenue by Application (2017-2028)

8.3 Asia Pacific Liraglutide Market Size by Region

8.3.1 Asia Pacific Liraglutide Sales by Region (2017-2028)

8.3.2 Asia Pacific Liraglutide Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Liraglutide Market Size by Type

9.1.1 Latin America Liraglutide Sales by Type (2017-2028)

9.1.2 Latin America Liraglutide Revenue by Type (2017-2028)

9.2 Latin America Liraglutide Market Size by Application

9.2.1 Latin America Liraglutide Sales by Application (2017-2028)

9.2.2 Latin America Liraglutide Revenue by Application (2017-2028)

9.3 Latin America Liraglutide Market Size by Country

9.3.1 Latin America Liraglutide Sales by Country (2017-2028)

9.3.2 Latin America Liraglutide Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Liraglutide Market Size by Type

10.1.1 Middle East and Africa Liraglutide Sales by Type (2017-2028)

10.1.2 Middle East and Africa Liraglutide Revenue by Type (2017-2028)

10.2 Middle East and Africa Liraglutide Market Size by Application

10.2.1 Middle East and Africa Liraglutide Sales by Application (2017-2028)

10.2.2 Middle East and Africa Liraglutide Revenue by Application (2017-2028)

10.3 Middle East and Africa Liraglutide Market Size by Country

10.3.1 Middle East and Africa Liraglutide Sales by Country (2017-2028)

10.3.2 Middle East and Africa Liraglutide Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 HEC Pharm

11.1.1 HEC Pharm Corporation Information

11.1.2 HEC Pharm Overview

11.1.3 HEC Pharm Liraglutide Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 HEC Pharm Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 HEC Pharm Recent Developments

11.2 Bachem

11.2.1 Bachem Corporation Information

11.2.2 Bachem Overview

11.2.3 Bachem Liraglutide Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Bachem Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Bachem Recent Developments

11.3 Bharat Pharmaceuticals

11.3.1 Bharat Pharmaceuticals Corporation Information

11.3.2 Bharat Pharmaceuticals Overview

11.3.3 Bharat Pharmaceuticals Liraglutide Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Bharat Pharmaceuticals Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bharat Pharmaceuticals Recent Developments

11.4 Kingpep Biotechnology

11.4.1 Kingpep Biotechnology Corporation Information

11.4.2 Kingpep Biotechnology Overview

11.4.3 Kingpep Biotechnology Liraglutide Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Kingpep Biotechnology Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Kingpep Biotechnology Recent Developments

11.5 Shenzhen JYMed Technology

11.5.1 Shenzhen JYMed Technology Corporation Information

11.5.2 Shenzhen JYMed Technology Overview

11.5.3 Shenzhen JYMed Technology Liraglutide Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Shenzhen JYMed Technology Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Shenzhen JYMed Technology Recent Developments

11.6 Wuxi Asiapeptide

11.6.1 Wuxi Asiapeptide Corporation Information

11.6.2 Wuxi Asiapeptide Overview

11.6.3 Wuxi Asiapeptide Liraglutide Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Wuxi Asiapeptide Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Wuxi Asiapeptide Recent Developments

11.7 AmbioPharm

11.7.1 AmbioPharm Corporation Information

11.7.2 AmbioPharm Overview

11.7.3 AmbioPharm Liraglutide Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 AmbioPharm Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 AmbioPharm Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Liraglutide Industry Chain Analysis

12.2 Liraglutide Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Liraglutide Production Mode & Process

12.4 Liraglutide Sales and Marketing

12.4.1 Liraglutide Sales Channels

12.4.2 Liraglutide Distributors

12.5 Liraglutide Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Liraglutide Industry Trends

13.2 Liraglutide Market Drivers

13.3 Liraglutide Market Challenges

13.4 Liraglutide Market Restraints

14 Key Findings in The Global Liraglutide Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

HEC Pharm

Bachem

Bharat Pharmaceuticals

Kingpep Biotechnology

Shenzhen JYMed Technology

List of Tables

Table 1. Global Liraglutide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Pills

Table 3. Major Manufacturers of Liquid

Table 4. Global Liraglutide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Liraglutide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Liraglutide Sales by Region (2017-2022) & (K MT)

Table 7. Global Liraglutide Sales Market Share by Region (2017-2022)

Table 8. Global Liraglutide Sales by Region (2023-2028) & (K MT)

Table 9. Global Liraglutide Sales Market Share by Region (2023-2028)

Table 10. Global Liraglutide Revenue by Region (2017-2022) & (US$ Million)

Table 11. Global Liraglutide Revenue Market Share by Region (2017-2022)

Table 12. Global Liraglutide Revenue by Region (2023-2028) & (US$ Million)

Table 13. Global Liraglutide Revenue Market Share by Region (2023-2028)

Table 14. Global Liraglutide Sales by Manufacturers (2017-2022) & (K MT)

Table 15. Global Liraglutide Sales Share by Manufacturers (2017-2022)

Table 16. Global Liraglutide Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 17. Global Liraglutide Revenue Share by Manufacturers (2017-2022)

Table 18. Liraglutide Price by Manufacturers (2017-2022) &(USD/MT)

Table 19. Global Liraglutide Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Liraglutide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liraglutide as of 2021)

Table 21. Liraglutide Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Liraglutide Product Offered

Table 23. Date of Manufacturers Enter into Liraglutide Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Liraglutide Sales by Type (2017-2022) & (K MT)

Table 26. Global Liraglutide Sales by Type (2023-2028) & (K MT)

Table 27. Global Liraglutide Sales Share by Type (2017-2022)

Table 28. Global Liraglutide Sales Share by Type (2023-2028)

Table 29. Global Liraglutide Revenue by Type (2017-2022) & (US$ Million)

Table 30. Global Liraglutide Revenue by Type (2023-2028) & (US$ Million)

Table 31. Global Liraglutide Revenue Share by Type (2017-2022)

Table 32. Global Liraglutide Revenue Share by Type (2023-2028)

Table 33. Liraglutide Price by Type (2017-2022) & (USD/MT)

Table 34. Global Liraglutide Price Forecast by Type (2023-2028) & (USD/MT)

Table 35. Global Liraglutide Sales by Application (2017-2022) & (K MT)

Table 36. Global Liraglutide Sales by Application (2023-2028) & (K MT)

Table 37. Global Liraglutide Sales Share by Application (2017-2022)

Table 38. Global Liraglutide Sales Share by Application (2023-2028)

Table 39. Global Liraglutide Revenue by Application (2017-2022) & (US$ Million)

Table 40. Global Liraglutide Revenue by Application (2023-2028) & (US$ Million)

Table 41. Global Liraglutide Revenue Share by Application (2017-2022)

Table 42. Global Liraglutide Revenue Share by Application (2023-2028)

Table 43. Liraglutide Price by Application (2017-2022) & (USD/MT)

Table 44. Global Liraglutide Price Forecast by Application (2023-2028) & (USD/MT)

Table 45. North America Liraglutide Sales by Type (2017-2022) & (K MT)

Table 46. North America Liraglutide Sales by Type (2023-2028) & (K MT)

Table 47. North America Liraglutide Revenue by Type (2017-2022) & (US$ Million)

Table 48. North America Liraglutide Revenue by Type (2023-2028) & (US$ Million)

Table 49. North America Liraglutide Sales by Application (2017-2022) & (K MT)

Table 50. North America Liraglutide Sales by Application (2023-2028) & (K MT)

Table 51. North America Liraglutide Revenue by Application (2017-2022) & (US$ Million)

Table 52. North America Liraglutide Revenue by Application (2023-2028) & (US$ Million)

Table 53. North America Liraglutide Sales by Country (2017-2022) & (K MT)

Table 54. North America Liraglutide Sales by Country (2023-2028) & (K MT)

Table 55. North America Liraglutide Revenue by Country (2017-2022) & (US$ Million)

Table 56. North America Liraglutide Revenue by Country (2023-2028) & (US$ Million)

Table 57. Europe Liraglutide Sales by Type (2017-2022) & (K MT)

Table 58. Europe Liraglutide Sales by Type (2023-2028) & (K MT)

Table 59. Europe Liraglutide Revenue by Type (2017-2022) & (US$ Million)

Table 60. Europe Liraglutide Revenue by Type (2023-2028) & (US$ Million)

Table 61. Europe Liraglutide Sales by Application (2017-2022) & (K MT)

Table 62. Europe Liraglutide Sales by Application (2023-2028) & (K MT)

Table 63. Europe Liraglutide Revenue by Application (2017-2022) & (US$ Million)

Table 64. Europe Liraglutide Revenue by Application (2023-2028) & (US$ Million)

Table 65. Europe Liraglutide Sales by Country (2017-2022) & (K MT)

Table 66. Europe Liraglutide Sales by Country (2023-2028) & (K MT)

Table 67. Europe Liraglutide Revenue by Country (2017-2022) & (US$ Million)

Table 68. Europe Liraglutide Revenue by Country (2023-2028) & (US$ Million)

Table 69. Asia Pacific Liraglutide Sales by Type (2017-2022) & (K MT)

Table 70. Asia Pacific Liraglutide Sales by Type (2023-2028) & (K MT)

Table 71. Asia Pacific Liraglutide Revenue by Type (2017-2022) & (US$ Million)

Table 72. Asia Pacific Liraglutide Revenue by Type (2023-2028) & (US$ Million)

Table 73. Asia Pacific Liraglutide Sales by Application (2017-2022) & (K MT)

Table 74. Asia Pacific Liraglutide Sales by Application (2023-2028) & (K MT)

Table 75. Asia Pacific Liraglutide Revenue by Application (2017-2022) & (US$ Million)

Table 76. Asia Pacific Liraglutide Revenue by Application (2023-2028) & (US$ Million)

Table 77. Asia Pacific Liraglutide Sales by Region (2017-2022) & (K MT)

Table 78. Asia Pacific Liraglutide Sales by Region (2023-2028) & (K MT)

Table 79. Asia Pacific Liraglutide Revenue by Region (2017-2022) & (US$ Million)

Table 80. Asia Pacific Liraglutide Revenue by Region (2023-2028) & (US$ Million)

Table 81. Latin America Liraglutide Sales by Type (2017-2022) & (K MT)

Table 82. Latin America Liraglutide Sales by Type (2023-2028) & (K MT)

Table 83. Latin America Liraglutide Revenue by Type (2017-2022) & (US$ Million)

Table 84. Latin America Liraglutide Revenue by Type (2023-2028) & (US$ Million)

Table 85. Latin America Liraglutide Sales by Application (2017-2022) & (K MT)

Table 86. Latin America Liraglutide Sales by Application (2023-2028) & (K MT)

Table 87. Latin America Liraglutide Revenue by Application (2017-2022) & (US$ Million)

Table 88. Latin America Liraglutide Revenue by Application (2023-2028) & (US$ Million)

Table 89. Latin America Liraglutide Sales by Country (2017-2022) & (K MT)

Table 90. Latin America Liraglutide Sales by Country (2023-2028) & (K MT)

Table 91. Latin America Liraglutide Revenue by Country (2017-2022) & (US$ Million)

Table 92. Latin America Liraglutide Revenue by Country (2023-2028) & (US$ Million)

Table 93. Middle East and Africa Liraglutide Sales by Type (2017-2022) & (K MT)

Table 94. Middle East and Africa Liraglutide Sales by Type (2023-2028) & (K MT)

Table 95. Middle East and Africa Liraglutide Revenue by Type (2017-2022) & (US$ Million)

Table 96. Middle East and Africa Liraglutide Revenue by Type (2023-2028) & (US$ Million)

Table 97. Middle East and Africa Liraglutide Sales by Application (2017-2022) & (K MT)

Table 98. Middle East and Africa Liraglutide Sales by Application (2023-2028) & (K MT)

Table 99. Middle East and Africa Liraglutide Revenue by Application (2017-2022) & (US$ Million)

Table 100. Middle East and Africa Liraglutide Revenue by Application (2023-2028) & (US$ Million)

Table 101. Middle East and Africa Liraglutide Sales by Country (2017-2022) & (K MT)

Table 102. Middle East and Africa Liraglutide Sales by Country (2023-2028) & (K MT)

Table 103. Middle East and Africa Liraglutide Revenue by Country (2017-2022) & (US$ Million)

Table 104. Middle East and Africa Liraglutide Revenue by Country (2023-2028) & (US$ Million)

Table 105. HEC Pharm Corporation Information

Table 106. HEC Pharm Description and Major Businesses

Table 107. HEC Pharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 108. HEC Pharm Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

Table 109. HEC Pharm Recent Developments

Table 110. Bachem Corporation Information

Table 111. Bachem Description and Major Businesses

Table 112. Bachem Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 113. Bachem Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Bachem Recent Developments

Table 115. Bharat Pharmaceuticals Corporation Information

Table 116. Bharat Pharmaceuticals Description and Major Businesses

Table 117. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 118. Bharat Pharmaceuticals Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Bharat Pharmaceuticals Recent Developments

Table 120. Kingpep Biotechnology Corporation Information

Table 121. Kingpep Biotechnology Description and Major Businesses

Table 122. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 123. Kingpep Biotechnology Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Kingpep Biotechnology Recent Developments

Table 125. Shenzhen JYMed Technology Corporation Information

Table 126. Shenzhen JYMed Technology Description and Major Businesses

Table 127. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 128. Shenzhen JYMed Technology Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Shenzhen JYMed Technology Recent Developments

Table 130. Wuxi Asiapeptide Corporation Information

Table 131. Wuxi Asiapeptide Description and Major Businesses

Table 132. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 133. Wuxi Asiapeptide Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Wuxi Asiapeptide Recent Developments

Table 135. AmbioPharm Corporation Information

Table 136. AmbioPharm Description and Major Businesses

Table 137. AmbioPharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 138. AmbioPharm Liraglutide Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. AmbioPharm Recent Developments

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Liraglutide Distributors List

Table 143. Liraglutide Customers List

Table 144. Liraglutide Market Trends

Table 145. Liraglutide Market Drivers

Table 146. Liraglutide Market Challenges

Table 147. Liraglutide Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Liraglutide Product Picture

Figure 3. Global Liraglutide Market Share by Type in 2021 & 2028

Figure 3. Pills Product Picture

Figure 4. Liquid Product Picture

Figure 5. Global Liraglutide Market Share by Application in 2021 & 2028

Figure 6. Hospital

Figure 7. Drug Store

Figure 8. Liraglutide Report Years Considered

Figure 9. Global Liraglutide Sales 2017-2028 (K MT)

Figure 10. Global Liraglutide Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Liraglutide Revenue 2017-2028 (US$ Million)

Figure 12. Global Liraglutide Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 13. Global Liraglutide Sales Market Share by Region (2017-2022)

Figure 14. Global Liraglutide Sales Market Share by Region (2023-2028)

Figure 15. North America Liraglutide Sales YoY (2017-2028) & (K MT)

Figure 16. North America Liraglutide Revenue YoY (2017-2028) & (US$ Million)

Figure 17. Europe Liraglutide Sales YoY (2017-2028) & (K MT)

Figure 18. Europe Liraglutide Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Asia-Pacific Liraglutide Sales YoY (2017-2028) & (K MT)

Figure 20. Asia-Pacific Liraglutide Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Latin America Liraglutide Sales YoY (2017-2028) & (K MT)

Figure 22. Latin America Liraglutide Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Middle East & Africa Liraglutide Sales YoY (2017-2028) & (K MT)

Figure 24. Middle East & Africa Liraglutide Revenue YoY (2017-2028) & (US$ Million)

Figure 25. The Liraglutide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 26. The Top 5 and 10 Largest Manufacturers of Liraglutide in the World: Market Share by Liraglutide Revenue in 2021

Figure 27. Global Liraglutide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 28. Global Liraglutide Sales Market Share by Type (2017-2028)

Figure 29. Global Liraglutide Revenue Market Share by Type (2017-2028)

Figure 30. Global Liraglutide Sales Market Share by Application (2017-2028)

Figure 31. Global Liraglutide Revenue Market Share by Application (2017-2028)

Figure 32. North America Liraglutide Sales Market Share by Type (2017-2028)

Figure 33. North America Liraglutide Revenue Market Share by Type (2017-2028)

Figure 34. North America Liraglutide Sales Market Share by Application (2017-2028)

Figure 35. North America Liraglutide Revenue Market Share by Application (2017-2028)

Figure 36. North America Liraglutide Sales Share by Country (2017-2028)

Figure 37. North America Liraglutide Revenue Share by Country (2017-2028)

Figure 38. U.S. Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 39. Canada Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 40. Europe Liraglutide Sales Market Share by Type (2017-2028)

Figure 41. Europe Liraglutide Revenue Market Share by Type (2017-2028)

Figure 42. Europe Liraglutide Sales Market Share by Application (2017-2028)

Figure 43. Europe Liraglutide Revenue Market Share by Application (2017-2028)

Figure 44. Europe Liraglutide Sales Share by Country (2017-2028)

Figure 45. Europe Liraglutide Revenue Share by Country (2017-2028)

Figure 46. Germany Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 47. France Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 48. U.K. Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 49. Italy Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 50. Russia Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 51. Asia Pacific Liraglutide Sales Market Share by Type (2017-2028)

Figure 52. Asia Pacific Liraglutide Revenue Market Share by Type (2017-2028)

Figure 53. Asia Pacific Liraglutide Sales Market Share by Application (2017-2028)

Figure 54. Asia Pacific Liraglutide Revenue Market Share by Application (2017-2028)

Figure 55. Asia Pacific Liraglutide Sales Share by Region (2017-2028)

Figure 56. Asia Pacific Liraglutide Revenue Share by Region (2017-2028)

Figure 57. China Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 58. Japan Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 59. South Korea Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 60. India Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 61. Australia Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 62. China Taiwan Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 63. Indonesia Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 64. Thailand Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 65. Malaysia Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 66. Latin America Liraglutide Sales Market Share by Type (2017-2028)

Figure 67. Latin America Liraglutide Revenue Market Share by Type (2017-2028)

Figure 68. Latin America Liraglutide Sales Market Share by Application (2017-2028)

Figure 69. Latin America Liraglutide Revenue Market Share by Application (2017-2028)

Figure 70. Latin America Liraglutide Sales Share by Country (2017-2028)

Figure 71. Latin America Liraglutide Revenue Share by Country (2017-2028)

Figure 72. Mexico Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 73. Brazil Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 74. Argentina Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 75. Middle East and Africa Liraglutide Sales Market Share by Type (2017-2028)

Figure 76. Middle East and Africa Liraglutide Revenue Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Liraglutide Sales Market Share by Application (2017-2028)

Figure 78. Middle East and Africa Liraglutide Revenue Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Liraglutide Sales Share by Country (2017-2028)

Figure 80. Middle East and Africa Liraglutide Revenue Share by Country (2017-2028)

Figure 81. Turkey Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 82. Saudi Arabia Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 83. UAE Liraglutide Revenue (2017-2028) & (US$ Million)

Figure 84. Liraglutide Value Chain

Figure 85. Liraglutide Production Process

Figure 86. Channels of Distribution

Figure 87. Distributors Profiles

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Liraglutide Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-17139

Global Liraglutide Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26X5859

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-6F14217

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-12I6253

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-10Q6255

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions